Table 1. Subjects in Training and Test Sets.
Variable | Training Sets (N=59) | Test Set (N=32) | P-value |
---|---|---|---|
Age at time of analysis, Median (Years, Min, Max) | 43 (10-88) | 42.0 (12-69) | 0.42 |
SEX, No. (%) | |||
Female | 29 (49%) | 16 (50%) | 1.00 |
Male | 30 (51%) | 16 (50%) | 1.00 |
B+CD27+IgM-IgD-, Median (Min, Max) | 1.0 (0.0, 22.4) | 1.1 (0.0, 6.0) | 0.90 |
IgG, Median (Min, Max) | 246.5 (6.0, 898.0) | 187.0 (13.0, 597.0) | 0.60 |
IgA, Median (Min, Max) | 8.2 (0.0, 535.0) | 7.0 (0.0, 95.0) | 0.21 |
IgM, Median (Min, Max) | 20.0 (3.0, 205.0) | 19.0 (1.0, 247.0) | 0.88 |
Complication, No. (%) | 0.66 | ||
No | 30 (51%) | 14 (44%) | |
Yes | 29 (49%) | 18 (56%) | |
Autoimmunity+, No. (%) | 0.63 | ||
No | 41 (69%) | 24 (75%) | |
Yes | 18 (31%) | 8 (25%) | |
Splenomegaly+, No. (%) | 0.80 | ||
No | 44 (75%) | 25 (78%) | |
Yes | 15 (25%) | 7 (22%) | |
Granuloma+ (Biopsy proven), No. (%) | 0.77 | ||
No | 50 (85%) | 26 (81%) | |
Yes | 9 (15%) | 6 (19%) | |
Lymphadenopathy/splenomegaly+, No. (%) | 0.43 | ||
No | 44 (75%) | 27 (84%) | |
Yes | 15 (25%) | 5 (16%) | |
Enteropathy, No. (%) | 0.10 | ||
No | 54 (92%) | 25 (78%) | |
Yes | 5 (8%) | 7 (22%) |
subjects commonly had more than one of these conditions.